pharmacie et médicaments – Médicaments innovants CAR-T face à la maladie melyome multiple

This written question concerns innovative CAR-T cell therapies for treating multiple myeloma, a type of blood cancer. It seeks information on the current situation and future prospects for these advanced treatments. The question addresses patients with multiple myeloma, healthcare providers, and the pharmaceutical industry. It aims to clarify access and availability of these cutting-edge therapies within the healthcare system.